Search
-
Flair France 2022: The end of promises?
The Ipsos Flair collection explores the social, economic, and political context in a selection of countries around the world. With passion and curiosity, our local experts capture the mood of the nation and transform survey results into inspiring insights.
-
Ipsos Update - April 2022
This month sees us reflect on the impacts of the Covid-19 pandemic two years on. Our featured global surveys cover topics including gender equality and interpersonal trust. We also look at the French election ahead of this month’s vote, alongside the latest polling on the Ukraine conflict.
-
Two Years On: Lessons From Covid Times
Two years into the unprecedented upheavals instigated by a global pandemic, it feels like a good moment to take stock and think about what we have learned during this dramatic period.
-
Leveraging Real-World Evidence to Drive Pricing & Access
The importance of Multiple Data Source Integration and Value Attribution in Multi-Component Disease Management.
-
Oncology in the Time of COVID
The COVID-19 pandemic has been challenging for healthcare systems worldwide – with an already overburdened system and large population, the Indian healthcare system was no exception.
-
The Path to Techquity
Ipsos partnered with the HLTH Foundation to shine a light on existing health tech-related inequities in the US and identify opportunities for the industry to address techquity gaps.
-
Three insights about why workers are quitting
Using social, survey, and search data our analysis uncovers new motivations driving worker resignations.
-
Ipsos Update - March 2022
Opinion polling, the year ahead in Brazil, gender inequality in Japan, and the future of ageing are all featured topics in this month’s round-up of research and thinking from Ipsos teams around the world.
-
Opinion Polls: A continual improvement process
Political opinion polls come under great scrutiny in the run-up to elections, as we try to make sense of often changing and sometimes fragmenting political landscapes. But by implementing new approaches and staying mindful of common sources of error, opinion polls can remain a vital tool for predicting election outcomes.
-
A Year in Oncology: A review of 2021 drug approvals in US, Europe and Japan
Whilst the global COVID-19 pandemic continued throughout 2021, new oncology drug and indication approvals maintained momentum across the US, Europe and Japan. These included continued roll-out and label expansions of Immuno-Oncology (I-O) therapies, along with treatments approved in Japan ahead of other global regions.